Abstract | OBJECTIVE: Searching for more potent and less toxic HMBA-related agents. METHODS: RESULTS: We found that the MEL DS19 cells were most sensitive to HMBA ( benzidine positive, B+ approximately 76%). Co- HDTA can inhibit the growth of MEL DS19, but induces differentiation just in a small population (B+ 2% approximately 4.5%). Between 0.02 approximately 5 micromol/L, HMBPA induces 3% approximately 8% cells committed to differentiation with little inhibition of cell proliferation. 1 micromol/L HMBPA and 2 mmol/L HMBA together, can obviously increase the percentage of differentiated cell (B+ approximately 72%), inhibit DNA synthesis and accelerate beta-globin transcription. CONCLUSION: The new HMBA derivatives may provide potential cancer differentiation inducers.
|
Authors | Huali Wang, Shifu Zhang, Jianping Zhou, Jingbo Zhang |
Journal | Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
(Chin Med Sci J)
Vol. 17
Issue 1
Pg. 27-31
(Mar 2002)
ISSN: 1001-9294 [Print] China |
PMID | 12894881
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acetamides
- Antineoplastic Agents
- Pyridines
- RNA, Messenger
- hexamethylenebi (3-pyridin) amide
- Globins
- hexamethylene bisacetamide
|
Topics |
- Acetamides
(chemistry, pharmacology)
- Animals
- Antineoplastic Agents
(pharmacology)
- Cell Differentiation
(drug effects)
- Cell Division
(drug effects)
- Globins
(biosynthesis, genetics)
- Humans
- K562 Cells
- Leukemia, Erythroblastic, Acute
(metabolism, pathology)
- Mice
- Pyridines
(chemistry, pharmacology)
- RNA, Messenger
(genetics)
- Tumor Cells, Cultured
|